Miroslav Zeman researcher (ORCID 0000-0001-5338-603X)
Zeman, Miroslav, liječnik
Zeman, Miroslav, 1950-
VIAF ID: 85187155 (Personal)
Permalink: http://viaf.org/viaf/85187155
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Altered activities of antioxidant enzymes in patients with metabolic syndrome | |
Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids. | |
Effects of dietary n-3 fatty acids on the composition of cholesteryl esters and triglycerides in plasma and liver perfusate of the rat | |
Glucose tolerance, insulin secretion, plasma lipid fatty acids, and the hypolipidemic effects of fish oil | |
The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. | |
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus | |
Mastné kyseliny a tuky ve zdraví a nemoci | |
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination | |
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place? | |
Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. | |
Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters | |
Pleiotropic effects of niacin : current possibilities for its clinical use | |
Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study. | |
The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic | |
Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study | |
Xanthomas: clinical and pathophysiological relations. |